The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024

Amendment to regulation 331

This section has no associated Explanatory Memorandum

129.  In regulation 331(1) (findings and reports of inspections)(1)—

(a)in the opening words, omit “, EU marketing authorisation”;

(b)in sub-paragraph (c), for “UKMA(UK)” substitute “UKMA(UK)(Category 2)”.

(1)

Paragraph (1) was amended by S.I. 2019/775 as amended by S.I. 2020/1488.